Delivery Order SPE2DR25D2014-SPE2DR26FA0X2
- Not listed
- The Defense Logistics Agency awarded a $1,066.74 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml). This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a $5,814.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). The contract is a non-set-aside award with an ultimate completion date of December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.04 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award utilizes firm fixed pricing and does not include a set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.46 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens (0.5 ml quantity) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,860.52 for Trulicity 3 mg/0.5 ml pen (0.5 ml units) with an ultimate completion date of December 8, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a single pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,180.40 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 8, 2025, with completion targeted for December 9, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical supply. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0X2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,898.88 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 29, 2025, with completion scheduled for December 30, 2025. This non-competitive, firm fixed-price delivery order represents a standard pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical supply needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The Trulicity order exemplifies the company's role in providing diabetes medications and other specialty pharmaceuticals through the DLA's flexible pharmaceutical support mechanism for federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/28/25 |